Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
When is the best time to visit North Carolina? Find out here!
Recommended
Top holiday events in the Triangle: Tree lightings, parades, and festive markets await
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sol-Gel Technologies Ltd
(NQ:
SLGL
)
0.5564
+0.0064 (+1.16%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,864
Open
0.5400
Bid (Size)
0.3708 (7)
Ask (Size)
0.5557 (7)
Prev. Close
0.5500
Today's Range
0.5398 - 0.5938
52wk Range
0.3340 - 1.575
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SLGL Stock Earnings: Sol-Gel Technologies Beats EPS, Beats Revenue for Q2 2024
August 16, 2024
SLGL stock results show that Sol-Gel Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 25, 2024
Via
Benzinga
Performance
YTD
-54.40%
-54.40%
1 Month
-15.95%
-15.95%
3 Month
+33.98%
+33.98%
6 Month
-15.70%
-15.70%
1 Year
-61.89%
-61.89%
More News
Read More
SLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024
May 20, 2024
Via
InvestorPlace
Sol-Gel Technologies: Q4 Earnings Insights
March 13, 2024
Via
Benzinga
Recap: Sol-Gel Technologies Q3 Earnings
November 09, 2023
Via
Benzinga
Expert Ratings for Sol-Gel Technologies
August 11, 2023
Via
Benzinga
Week in Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
May 19, 2024
Via
Talk Markets
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
Via
Benzinga
Sol-Gel Technologies: Q1 Earnings Insights
May 13, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
Via
Benzinga
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) Making Surprising Moves in Wednesday Session
March 22, 2023
Via
Investor Brand Network
7 Biotech Stocks That Could Be the Next Big Thing
March 15, 2023
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Via
Benzinga
The Top 7 Penny Stocks to Invest in for the Long-Term
February 23, 2023
Via
InvestorPlace
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
November 14, 2022
Via
Benzinga
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 22, 2023
Via
Benzinga
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
November 07, 2022
Via
Benzinga
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
October 24, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
October 21, 2022
Via
Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
June 29, 2022
Via
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Via
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Via
Benzinga
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
July 15, 2022
Via
Benzinga
Earnings Scheduled For August 4, 2021
August 04, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.